Abstract
Gliomas are highly invasive and lethal malignancy that do not respond to current therapeutic approaches. Novel therapeutic agents are required to target molecular mechanisms involved in glioma progression. MeICT is a new short-chain toxin isolated from Mesobuthus eupeus scorpion venom. This toxin contained 34 amino acid residues and belongs to chloride channels toxins. In this study, the coding sequence of MeICT was cloned into the pET32Rh vector and a high yield of soluble recombinant MeICT was expressed and purified. Recombinant MeICT-His significantly inhibited the proliferation and migration of glioma cells at low concentration. In vivo studies showed that MeICT was not toxic when administrated to mice at high doses. We also determined the effect of MeICT on the mRNA expression of MMP-2, Annexin A2 and FOXM-2 that are key molecules in the progression and invasion of glioma. Expression of Annexin A2 and FOXM1 mRNA was significantly down-regulated following treatment with MeICT. However, no significant decrease in the expression of MMP-2 gene was identified. In this study a short toxin with four disulfide bonds was successfully produced and its anti-cancer effects was detected. Our findings suggest that recombinant MeICT can be considered as a new potent agent for glioma targeting.
Similar content being viewed by others
References
Bogomolovas J, Simon B, Sattler M, Stier G (2009) Screening of fusion partners for high yield expression and purification of bioactive viscotoxins. Protein Expr Purif 64:16–23
Cheng SH, Tu Y, Zhang S (2013) FOXM1 promotes glioma cells progression by up-regulating Anxa1 expression. PLoS ONE 8:1–10
Cheng Y, Zhao J, Qiao W, Chen K (2014) Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates. Am J Nucl Med Mol 4:385–405
Chetty C, Bhoopathi P, Rao JS, Lakka S (2009) Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer 124(10):2468–2477
Dai B, Kang SH, Gong W et al (2007) Aberrant FOXM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 26:6212–6219
Dardevet L, Rani D, Abd El Aziz T et al (2015) Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion. Toxins 7:1079–1101
Dastpeyman M, Giacomin P, Wilson D et al (2019) A C-terminal fragment of chlorotoxin retains bioactivity and inhibits cell migration. Front Pharmacol 10(250):1–10
Deshane J, Garner CC, Sontheimer H (2003) Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278:4135–4144
El-Ghlban S, Kasai T, Shigehiro T et al (2014) Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic cancer cells. BioMed Res Int 1:1–10
Esposito D, Chatterjee DK (2006) Enhancement of soluble protein expression through the use of fusion tags. Currt Opin Biotechnol 17:353–358
Farsani FM, Ayat H, Ahadi AM (2015) Molecular modeling and docking studies on the first chlorotoxin-like peptide from Iranian scorpion Mesobuthus eupeus (Meict) and SNP variants of matrix methaloproteinase-2 (MMP-2). Iran J Toxicol 9:1368–1376
Fau YJ, Yin LT, Liang AH et al (2007) Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. Neurosci Lett 412:62–67
Fu YJ, An N, Chan KG et al (2011) A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study. Biotechnol Lett 33:1309–1317
Halasi M, Gartel AL (2013) Targeting FOXM1 in cancer. Biochem Pharmacol 85:644–652
Ilkhanizade S, Ayat H, Ahadi AM, Pirali K (2011) Sequencing and comparative-bioinformatic analysis of chlorotoxin-like peptide from Iranian scorpion Mesobuthus eupeus. J SKU Med Sci 13:27–36
Kesavan K, Ratliff J, Johnson EW et al (2009) Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. J Biol Chem 285:4366–4374
LaVallie ER, Lu Z, Diblasio-Smith EA, Collins-Racie LA, McCoy JM (2000) Thioredoxin as a fusion partner for production of soluble recombinant proteins in Escherichia coli. Methods Enzymol 326:322–340
Liang J, Lv X, Lu C et al (2020) Prognostic factors of patients with Gliomas: an analysis on 335 patients with Glioblastoma and other forms of Gliomas. BMC Cancer 20(35):1–7
Liao G, Li X, Zeng S, Liu C, Yang S, Yang L, Hu C, Bai J (2018) Regulation of the master regulator FOXM1 in cancer. J Cell Commun Signal 16(57):1–15
Lyukmanova EN, Shulepko MA, Shenkarev ZO, Dolgikh DA, Kirpichnikov MP (2010) In vitro production of three-finger neurotoxins from snake venoms, a disulfide rich proteins. Problems and their solutions (Review). Russ J Bioorg Chem 36:137–145
Othman H, Wieninger SA, ElAyeb M et al (2017) In silico prediction of the molecular basis of ClTx and AaCTx interaction with matrix metalloproteinase-2 (MMP-2) to inhibit glioma cell invasion. J Biomol Struct Dyn 35:2815–2829. https://doi.org/10.1080/07391102.2016.1231633
Pullen NA, Pickford AR, Perry MM et al (2018) Current insights into matrix metalloproteinases and glioma progression: transcending the degradation boundary. Metalloproteinases Med 5:13–30
Rezaei L, Ayat H, Ahadi AM (2021) Design and construction of pET32b(+) Rh expression vector based on pET system to facilitate purification. J Cell Mol Res 34(2):169–181
Rjeibi K, Mabrouk H, Mosrati C et al (2011) Purification, synthesis and characterization of AaCTX, the first chlorotoxin-like peptide from Androctonus australis scorpion venom. Peptides 32:656–663
Roomi MW, Ivanov V, Kalinovsky T et al (2007) Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture. Med Oncol 24:231–238
Sharma MC (2019) Annexin A2 (ANNEXIN A2): An emerging biomarker and potential therapeutic target for aggressive cancers. Int J Cancer 144:2074–2081
Sun N, Zhao L, Qiao W et al (2017) BmK CT and I-BmK CT suppress the invasion of glioma cells in vitro via matrix metalloproteinase-2. Mol Med Rep 15:2703–2708
Turner KL, Sontheimer H (2014) Cl- and K+ channels and their role in primary brain tumour biology. Philos Trans R Soc B 369:1–9
Wang CY, Lin CF (2014) Annexin A2: its molecular regulation and cellular expression in cancer development dis markers 1–10.
Xu T, Fan Z, Li W et al (2016) Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Sci Rep 25:1–14
Zhai H, Acharya S, Gravanis I et al (2011) Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci 31(40):14346–14360
Zhang X, LV Q, Huang Y et al (2017) Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma. J Exp Clin Cancer Res 36:1–18
Zhao P, Zhang W, Tang J et al (2010) Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 101:387–395
Acknowledgements
We thank Dr. Hossein Asadi for providing U87-MG cell line and Dr. Smayeh Reiisi for technical assistance. This study was supported by Shahrekord University.
Funding
This work was supported by Shahrekord University.
Author information
Authors and Affiliations
Contributions
MSG: investigation, methodology, visualization roles, writing original draft. HA: supervision, conceptualization, project administration, validation, writing, review and editing. AMA: data analysis, writing, review and editing.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare they have no conflict of interest.
Ethical approval
The permission for experimental animal procedures was obtained from Animal Ethics Committee of Shahrekord University.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gandomkari, M.S., Ayat, H. & Ahadi, A.M. Recombinantly expressed MeICT, a new toxin from Mesobuthus eupeus scorpion, inhibits glioma cell proliferation and downregulates Annexin A2 and FOXM1 genes. Biotechnol Lett 44, 703–712 (2022). https://doi.org/10.1007/s10529-022-03254-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-022-03254-x